[Canceromimetic properties of the tetrachloro-2,3,7,8 dibenzo-p-dioxin ("dioxin")].
D000818:Animals; D001119:Arginase / Q000032:analysis*; D002273:Carcinogens / Q000633:toxicity*; D004147:Dioxins / Q000633:toxicity*; D004790:Enzyme Induction / Q000187:drug effects*; D006016:Glycolates / Q000494:pharmacology; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000096:biosynthesis; D010243:Paralysis / Q000139:chemically induced; D010634:Phenobarbital / Q000378:metabolism; D010636:Phenols / Q000494:pharmacology; D051381:Rats; D012890:Sleep; D013997:Time Factors; D015049:Zoxazolamine
D002273:Carcinogens; D004147:Dioxins; D006016:Glycolates; D010636:Phenols; D015049:Zoxazolamine; D006899:Mixed Function Oxygenases; D001119:Arginase; D010634:Phenobarbital
Propriétés cancéromimétiques de la tétrachloro-2,3,7,8 dibenzo-p-dioxine ("dioxine")